Article Information
History
- May 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lotus L. van den Hoogen1,
- Mardi C. Boer1,
- Abigail Postema1,
- Lia de Rond1,
- Mary-lène de Zeeuw-Brouwer1,
- Inge Pronk1,
- Alienke J. Wijmenga-Monsuur1,
- Elske Bijvank1,
- Caitlyn Kruiper1,
- Lisa Beckers1,
- Marjan Bogaard-van Maurik1,
- Ilse Zutt1,
- Jeffrey van Vliet1,
- Rianne van Bergen1,
- Marjan Kuijer1,
- Gaby Smits1,
- W. M. Monique Verschuren,
- H. Susan J. Picavet,
- Fiona R.M. van der Klis1,
- Gerco den Hartog1,
- Robert S. van Binnendijk1 and
- Anne-Marie Buisman1,*
- 1Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- 2Centre for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
- ↵*Corresponding author; email: annemarie.buisman{at}rivm.nl
Posted May 19, 2022.
Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from a large study performed in the general population aged 12 to 92 years
